BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3859216)

  • 1. Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency.
    Gibson TP; Demetriades JL; Bland JA
    Am J Med; 1985 Jun; 78(6A):54-61. PubMed ID: 3859216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers.
    Drusano GL; Standiford HC
    Am J Med; 1985 Jun; 78(6A):47-53. PubMed ID: 3859215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of imipenem and cilastatin in volunteers.
    Rogers JD; Meisinger MA; Ferber F; Calandra GB; Demetriades JL; Bland JA
    Rev Infect Dis; 1985; 7 Suppl 3():S435-46. PubMed ID: 3863219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of the pharmacology of imipenem/cilastatin.
    Drusano GL
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():79-92. PubMed ID: 3546249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-dose study of imipenem/cilastatin in patients with end-stage renal disease undergoing long-term hemodialysis.
    Berman SJ; Sugihara JG; Nakamura JM; Kawahara KK; Wong EG; Musgrave JE; Wong LM; Siemsen AM
    Am J Med; 1985 Jun; 78(6A):113-6. PubMed ID: 3859209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients.
    Engelhard D; Shalit I; Stutman HR; Greenwood R; Griffis J; Marks MI
    Pediatr Pharmacol (New York); 1986; 5(4):273-9. PubMed ID: 3461422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.
    Verpooten GA; Verbist L; Buntinx AP; Entwistle LA; Jones KH; De Broe ME
    Br J Clin Pharmacol; 1984 Aug; 18(2):183-93. PubMed ID: 6593092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose pharmacokinetics of imipenem-cilastatin.
    Drusano GL; Standiford HC; Bustamante C; Forrest A; Rivera G; Leslie J; Tatem B; Delaportas D; MacGregor RR; Schimpff SC
    Antimicrob Agents Chemother; 1984 Nov; 26(5):715-21. PubMed ID: 6595963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.
    Reed MD; Stern RC; O'Brien CA; Yamashita TS; Myers CM; Blumer JL
    Antimicrob Agents Chemother; 1985 Apr; 27(4):583-8. PubMed ID: 3859245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of imipenem-cilastatin in neonates.
    Freij BJ; McCracken GH; Olsen KD; Threlkeld N
    Antimicrob Agents Chemother; 1985 Apr; 27(4):431-5. PubMed ID: 3859242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis.
    Somani P; Freimer EH; Gross ML; Higgins JT
    Antimicrob Agents Chemother; 1988 Apr; 32(4):530-4. PubMed ID: 3377464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose pharmacokinetics of imipenem-cilastatin in neonates.
    Gruber WC; Rench MA; Garcia-Prats JA; Edwards MS; Baker CJ
    Antimicrob Agents Chemother; 1985 Apr; 27(4):511-4. PubMed ID: 3859243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin: rationale for a fixed combination.
    Norrby SR
    Rev Infect Dis; 1985; 7 Suppl 3():S447-51. PubMed ID: 3863220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic studies of imipenem/cilastatin in elderly patients.
    Finch RG; Craddock C; Kelly J; Deaney NB
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():103-7. PubMed ID: 3469182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of imipenem and cilastatin after their simultaneous administration to the elderly.
    Toon S; Hopkins KJ; Garstang FM; Aarons L; Rowland M
    Br J Clin Pharmacol; 1987 Feb; 23(2):143-9. PubMed ID: 3470047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal clearance of imipenem in children.
    Jacobs RF; Kearns GL; Brown AL; Trang JM; Kluza RB
    Eur J Clin Microbiol; 1984 Oct; 3(5):471-4. PubMed ID: 6594236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in the pediatric field. Pediatric Study Group for Imipenem/Cilastatin Sodium].
    Fujii R; Meguro H; Arimasu O; Yoshioka H; Fujita K; Maruyama S; Inyaku F; Nagamatsu I; Wagatsuma Y; Takase A
    Jpn J Antibiot; 1986 Jul; 39(7):1912-37. PubMed ID: 3464785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.
    Verbist L; Verpooten GA; Giuliano RA; Debroe ME; Buntinx AP; Entwistle LA; Jones KH
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():115-20. PubMed ID: 3469184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone concentrations of imipenem after a dose of imipenem/cilastatin].
    Wittmann DH; Kuipers TH; Fock R; Höll M; Bauernfeind A
    Infection; 1986; 14 Suppl 2():S130-7. PubMed ID: 3463540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers.
    Drusano GL; Standiford HC; Bustamante CI; Forrest A; Rivera G; Tatem B; Schimpff SC
    Eur J Clin Microbiol; 1984 Oct; 3(5):468-70. PubMed ID: 6594235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.